Is Kinesio Taping Treatment Effective in Children With Cerebral Palsy?

NCT03819205 | Unknown

• 1 other identifier: DorkuzEUZTOKEL
• Study Type: interventional
• Target: 34
• Locations: 1 country
• Sites: 1

Brief Summary

Cerebral palsy (CP) is defined as a non-progressive lesion of the immature brain. Children with CP may present with a variety of motor impairments. The impaired upper limb function of children with cerebral palsy (CP) limits and restricts participation in activities of daily living. Kinesio Taping (KT) is commonly used in sport injuries, in neurology and oncology patients following the surgical protocols, and for pediatric rehabilitation to reduce pain, facilitate or inhibit muscle activity, prevent injuries, reposition joints, aid the lymphatic system, support postural alignment, and improve proprioception. Kinesiotaping is a treatment that has not been studied much and can be applied in cerebral palsy. The tapes were grouped as elastic and rigid. In fact, there has been a few studies that investigates the effect of upper extremity elastic kinesiotaping. High methodological studies about its efficacy in this population are rare.

Conditions

Cerebral Palsy

Keywords

cerebral palsy; upper extremity kinesiotaping; modified house

Outcome Measures

Primary Outcomes (2)

• Box and block test

  With the stopwatch, it is recorded how many small cubes are transferred to the other side of the box within 60 seconds.

  1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)

• Nine hole peg test

  A wooden box with nine holes is placed in front of the patient and held in seconds with the stopwatch. Insersion and extraction time of pegs in second are noted.

  1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)

Secondary Outcomes (2)

• Modified house clasification score

  1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)

• Active/passive wrist dorsiflexion range of motion

  1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)

Study Arms (1)

kinesiotaping group(before/after)

EXPERIMENTAL

* Hemiplegic CP:Kinesiotaping on the affected side * Diplegic, tetraplegic CP: side of upper extremity which children have been used to but have obstacles in daily life * intervention Duration: For 1 week at least 2-3 hours a day, renewing if it's necessary. * Note:Patients will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day. * Evaluation: In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion

Other: kinesiotaping

Interventions

kinesiotaping OTHER

The participants will receive kinesiotaping treatment on the affected side for the hemiplegic CP's and for diplegic, tetraplegic CP's the side of upper extremity which children have been used to but have obstacles in daily life for 1 week at least 2-3 hours a day, renewing if it's necessary. The participants will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day. In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion

kinesiotaping group(before/after)

Eligibility Criteria

• Age: 6 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Age between 6-18
• Following up with diagnose of hemiplegic/diplegic/tetraplegic CP patients with current imaginig findings
• Patient with stable clinical status
• Stage ≤2 patients depended on the modified ascwort scale
• Patients who are eligible to participate the study tests with suitable cognitive state
• Patients who agreed to participate the study.

You may not qualify if:

• Stage \>2 patients depended on the modified ascwort scale
• Botilinum toxin intervention to the upper extremity in the last 6 months.
• Patients who undergo upper extremity surgery.
• Patients who have contraindication for kinesiotaping (Wide and severe skin injury, open wounds at risk of infection , allergic reactions)
• Patients with intense sensory and motor loss in the banding area
• Patients classified in stage IIB and above according to Zancolli stage

Sponsors & Collaborators

• Dokuz Eylul University: lead

Study Sites (1)

Dokuz Eylul University

Izmir, İ̇zmi̇r, 35340, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, Chronic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Study Officials

• Zeynep Tokel, MD

  Dokuz Eylul University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Zeynep Tokel

CONTACT

+905068535386; zeyneptkl343@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: : Principal investigator

Model Details: self-controlled study

Study Record Dates

• First Submitted: January 23, 2019
• First Posted: January 28, 2019
• Study Start: April 15, 2018
• Primary Completion: March 10, 2019
• Study Completion: March 10, 2019
• Last Updated: January 29, 2019

Record last verified: 2019-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)